Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid

Overview of attention for article published in Clinical Epigenetics, April 2011

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 8 patents

Citations

dimensions_citation: 44 Dimensions

Readers on

mendeley: 49 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 8 patents that reference this research output.

Histone deacetylase inhibitors

Grant US-10870624-B2

United States of America

Polyheteroarl histone deacetylase inhibitors and their use in therapy

Grant US-10533003-B2

United States of America

Diheteroaryl histone deacetylase inhibitors and their use in therapy

Grant US-10407435-B2

United States of America

Histone deacetylase inhibitors and their use in therapy

Grant US-10150763-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 4 additional patents.